News

People with PCOS who struggle to conceive tend to have lower levels of a gut microbe that has been linked to endometrial ...
A risk of complication following treatment with gonadotropins in polycystic ovary syndrome (PCOS) patients is an ovarian hyperstimulation syndrome (OHSS). Although some molecular mechanisms have been ...
Polycystic Ovary Syndrome (PCOS), the leading cause of infertility worldwide, is characterised by oligo-anovulation, hyperandrogenism, polycystic ovarian morphology and high Anti-Müllerian hormone ...
Polycystic ovarian syndrome (PCOS) is a common endocrine disorder in women of childbearing age, characterized by hyperandrogenism, dysovulation and menstrual cycle disorders. Numerous scientific works ...
ABSTRACT Objective Polycystic ovary syndrome (PCOS) is an endocrine disease characterized by metabolic, reproductive, and psychological manifestations. Growth and differentiation factor 15 (GDF-15) is ...
INTRODUCTION Polycystic ovary syndrome (PCOS) is a highly prevalent endocrine disorder that affects females aged 15 to 49 years, with a frequency of up to 20% 1. PCOS is a heterogeneous condition and ...
Polycystic ovary syndrome (PCOS) mobilized hematopoietic progenitor cells in the bone marrow, leading to increased circulating hematopoietic progenitor cells; meanwhile, splenic norepinephrine content ...
Figure 1. Characterization of reproductive and metabolic phenotypes in a polycystic ovary syndrome mouse model. A, Schematic illustration showing the induction of polycystic ovary syndrome (PCOS) by ...
The authors systematically searched PubMed, an electronic database, using keywords such as alpha lipoic acid, α lipoic acid, alpha-lipoic acid, polycystic ovary syndrome, and PCOS.
Over the past decade, she has established herself as one of the leading international scientists in the field of polycystic ovary syndrome (PCOS) and is currently ranked 8th on the global expert list.
In polycystic ovary syndrome (PCOS), the following changes take place in the ovarian tissues (Abbott et al., 2006): enlarged, sclerotic, and multiple cystic follicles, whole ovarian hypertrophy, ...